Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (151-160 of 255) with videos related to

Pageof 26
Sort By:
Clinical Immunology and Immunopathology|April 1, 1993
Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-IR B Lal, C Buckner, R F Khabbaz, et al.
Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosanMark A Webber, Michelle M C Buckner, Liam S Redgrave, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigationShauna L Hillman, Sumithra J Mandrekar, Brian Bot, et al.
Scientific Reports|June 5, 2026
Whole-genome sequencing reveals high-risk ESBL and carbapenemase-producing Enterobacterales on maternity ward surfaces in CameroonGabriel Cedric Bessala, Germanie Delaisie Abomo, Henri Rodrigue Njengoue Ngamaleu, et al.
Journal of Geriatric Oncology|May 21, 2016
Pragmatic study designs for older adults with cancer: Report from the U13 conferenceRyan D Nipp, Nengliang Aaron Yao, Lisa M Lowenstein, et al.
Journal of Neuro-Oncology|December 1, 1990
Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytomaJ C Buckner, L D Brown, T L Cascino, et al.
The Journal of Infectious Diseases|November 1, 1992
Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populationsC Buckner, C R Roberts, S K Foung, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
Cancer|April 25, 2003
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment GroupJan C Buckner, Joel M Reid, Keith Wright, et al.
Pageof 26

Showing results (151-160 of 255) with videos related to

Sort By:
Pageof 26
Clinical Immunology and Immunopathology|April 1, 1993
Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-IR B Lal, C Buckner, R F Khabbaz, et al.
Mayo Clinic Proceedings|March 9, 1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent gliomaJ C Buckner, M G Malkin, E Reed, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosanMark A Webber, Michelle M C Buckner, Liam S Redgrave, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigationShauna L Hillman, Sumithra J Mandrekar, Brian Bot, et al.
Scientific Reports|June 5, 2026
Whole-genome sequencing reveals high-risk ESBL and carbapenemase-producing Enterobacterales on maternity ward surfaces in CameroonGabriel Cedric Bessala, Germanie Delaisie Abomo, Henri Rodrigue Njengoue Ngamaleu, et al.
Journal of Geriatric Oncology|May 21, 2016
Pragmatic study designs for older adults with cancer: Report from the U13 conferenceRyan D Nipp, Nengliang Aaron Yao, Lisa M Lowenstein, et al.
Journal of Neuro-Oncology|December 1, 1990
Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytomaJ C Buckner, L D Brown, T L Cascino, et al.
The Journal of Infectious Diseases|November 1, 1992
Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populationsC Buckner, C R Roberts, S K Foung, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
Cancer|April 25, 2003
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment GroupJan C Buckner, Joel M Reid, Keith Wright, et al.
Pageof 26